Introduction of SLC6A12
SLC6A12 is encoded by SLC6A12 gene. It belongs to the solute carrier family 6 which has been extensively studied during the past few decades because it offers numerous possibilities for therapeutic applications. SLC6A12 mediates the transport of the neurotransmitter GABA, but with a lower affinity compared to other GABA transporters. Meanwhile, many studies conducted on SLC6A12 show that it is related to various diseases, such as traumatic glaucoma and spinocerebellar ataxia 11.
Basic Information of SLC6A12 | |
Protein Name | Sodium- and chloride-dependent betaine transporter |
Gene Name | SLC6A12 |
Aliases | BGT1 |
Organism | Homo sapiens (Human) |
UniProt ID | P48065 |
Transmembrane Times | 12 |
Length (aa) | 614 |
Sequence | MDGKVAVQECGPPAVSWVPEEGEKLDQEDEDQVKDRGQWTNKMEFVLSVAGEIIGLGNVWRFPYLCYKNGGGAFFIPYFIFFFVCGIPVFFLEVALGQYTSQGSVTAWRKICPLFQGIGLASVVIESYLNVYYIIILAWALFYLFSSFTSELPWTTCNNFWNTEHCTDFLNHSGAGTVTPFENFTSPVMEFWERRVLGITSGIHDLGSLRWELALCLLLAWVICYFCIWKGVKSTGKVVYFTATFPYLMLVILLIRGVTLPGAYQGIIYYLKPDLFRLKDPQVWMDAGTQIFFSFAICQGCLTALGSYNKYHNNCYKDCIALCFLNSATSFVAGFVVFSILGFMSQEQGVPISEVAESGPGLAFIAFPKAVTMMPLSQLWSCLFFIMLIFLGLDSQFVCVECLVTASIDMFPRQLRKSGRRELLILTIAVMCYLIGLFLVTEGGMYIFQLFDYYASSGICLLFLSLFEVVCISWVYGADRFYDNIEDMIGYRPWPLVKISWLFLTPGLCLATFLFSLSKYTPLKYNNVYVYPPWGYSIGWFLALSSMVCVPLFVVITLLKTRGPFRKRLRQLITPDSSLPQPKQHPCLDGSAGRNFGPSPTREGLIAGEKETHL |
Function of SLC6A12 Membrane Protein
SLC6A12, also named as betaine transporter 1 (BGT1), is the osmolyte branch of the human neurotransmitter sodium symporter (NSS). It can mainly express in brain, liver, and kidney. Recent studies have indicated that SLC6A12 plays a role in controlling brain excitability and thereby represents a target for anticonvulsive drug development. In addition, research has confirmed several SLC6A12 variants could be used as biomarkers in epilepsy.
Fig.1 Sequence alignment and homology model of the NSS family transporter BGT-1. (Schweikhard, 2015)
Application of SLC6A12 Membrane Protein in Literature
This article analyzes the expression and promoter CpG sites methylation levels of SLC6A12 in a xenograft mouse with ovarian cancer. These results indicate that SLC6A12 is highly expressed in mouse and its DNA methylation of promoter CpG sites is decreased in tumor metastases.
This article reports that the relationship between the two functional SLC6A12 mutations and temporal lobe epilepsy. These results indicate that rs542736 G-rs557881 A haplotypes could be potential therapeutic targets for this disease.
Authors in this group identify the function of SLC6A12 in brain, kidney, and liver. The data suggest betaine plays an important role in transcriptional regulation of BGT1.
SLC6A12 Preparation Options
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC6A12 antibody development services.
As a forward-looking research institute as well as a leading custom service provider in the field of membrane protein, Creative Biolabs has won good reputation among our worldwide customers for successfully accomplishing numerous challenging projects including generation of many functional membrane proteins. Please feel free to contact us for more information.
Reference
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.